Development of a potent 2-oxoamide inhibitor of secreted phospholipase A2 guided by molecular docking calculations and molecular dynamics simulations.
about
Inhibitors of phospholipase A2 and their therapeutic potential: an update on patents (2012-2016).Structural Insight into Binding Mode of 9-Hydroxy Aristolochic Acid, Diclofenac and Indomethacin to PLA2.Discovery of AZD2716: A Novel Secreted Phospholipase A2 (sPLA2) Inhibitor for the Treatment of Coronary Artery Disease.2-Oxoesters: A Novel Class of Potent and Selective Inhibitors of Cytosolic Group IVA Phospholipase A2.2-Oxoamides based on dipeptides as selective calcium-independent phospholipase A2 inhibitors.Small Peptides Able to Suppress Prostaglandin E₂ Generation in Renal Mesangial Cells.
P2860
Development of a potent 2-oxoamide inhibitor of secreted phospholipase A2 guided by molecular docking calculations and molecular dynamics simulations.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Development of a potent 2-oxoa ...... olecular dynamics simulations.
@en
Development of a potent 2-oxoa ...... olecular dynamics simulations.
@nl
type
label
Development of a potent 2-oxoa ...... olecular dynamics simulations.
@en
Development of a potent 2-oxoa ...... olecular dynamics simulations.
@nl
prefLabel
Development of a potent 2-oxoa ...... olecular dynamics simulations.
@en
Development of a potent 2-oxoa ...... olecular dynamics simulations.
@nl
P2093
P2860
P1476
Development of a potent 2-oxoa ...... olecular dynamics simulations.
@en
P2093
Efrosini Barbayianni
George Kokotos
Georgios Leonis
Manthos G Papadopoulos
Sofia Vasilakaki
Thomas Mavromoustakos
P2860
P304
P356
10.1016/J.BMC.2016.02.040
P407
P577
2016-03-02T00:00:00Z